因美纳拟收购SomaLogic

Core Viewpoint - The company Invenia has reached a final agreement to acquire SomaLogic and other specified assets for $350 million in cash, building on a previous collaboration established in December 2021 [1] Group 1 - The acquisition aims to integrate SomaScan® proteomics testing into Invenia's high-throughput next-generation sequencing (NGS) platform [1]